Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy

por Haider, Ahmad, Haider, Karim S, Saad, Farid
Publicado 2017

Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for “late-onset” hypogonadism: A case report

por Haider, Ahmad, Haider, Karim, Saad, Farid, Hanefeld, Markolf
Publicado 2019

Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild l...

por Saad, Farid, Doros, Gheorghe, Haider, Karim Sultan, Haider, Ahmad
Publicado 2018

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Yea...

por Haider, Karim, Haider, Ahmad, Doros, Gheorghe, Traish, Abdulmaged, Saad, Farid
Publicado 2019

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisp...

por Haider, Ahmad, Haider, Karim, Doros, Gheorghe, Traish, Abdulmaged, Saad, Farid
Publicado 2019

SUN-083 Hypertension and Hemodynamic Parameters in Men with Hypogonadism Improve Under Long-Term Treatment with Testosterone Undecanoate Injections (TU) Compared to Untreated Hypog...

por Saad, Farid, Haider, Karim, Haider, Ahmad, Doros, Gheorghe, Traish, Abdulmaged
Publicado 2019

SUN-055 Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism Treated with Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoa...

por Saad, Farid, Haider, Ahmad, Haider, Karim, Doros, Gheorghe, Traish, Abdulmaged
Publicado 2019

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Pat...

por Haider, Karim, Haider, Ahmad, Doros, Gheorghe, Traish, Abdulmaged, Saad, Farid
Publicado 2019

OR21-2 Lipid Profiles Improve in Men With Hypogonadism and Pre-existing Cardiovascular Disease Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (...

por Haider, Ahmad, Haider, Karim, Doros, Gheorghe, Traish, Abdulmaged, Saad, Farid
Publicado 2019

Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setti...

por Traish, Abdulmaged M., Haider, Ahmad, Haider, Karim Sultan, Doros, Gheorghe, Saad, Farid
Publicado 2017

Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study

por Haider, Ahmad, Yassin, Aksam, Haider, Karim Sultan, Doros, Gheorghe, Saad, Farid, Rosano, Giuseppe MC
Publicado 2016

Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐worl...

por Haider, Karim Sultan, Haider, Ahmad, Saad, Farid, Doros, Gheorghe, Hanefeld, Markolf, Dhindsa, Sandeep, Dandona, Paresh, Traish, Abdulmaged
Publicado 2020

Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational,...

por Alwani, Mustafa, Yassin, Aksam, Talib, Raidh, Al-Qudimat, Ahmad, Aboumarzouk, Omar, Al-Zoubi, Raed M, Saad, Farid, Haider, Karim S, Al Ansari, Abdulla
Publicado 2021